IFG Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.95M | Buy |
3,781
+54
| +1% | +$42.1K | 0.15% | 174 |
|
2025
Q1 | $3.08M | Buy |
3,727
+641
| +21% | +$529K | 0.17% | 151 |
|
2024
Q4 | $2.38M | Buy |
3,086
+288
| +10% | +$222K | 0.14% | 185 |
|
2024
Q3 | $2.48M | Sell |
2,798
-182
| -6% | -$161K | 0.16% | 169 |
|
2024
Q2 | $2.7M | Sell |
2,980
-177
| -6% | -$160K | 0.17% | 149 |
|
2024
Q1 | $2.46M | Buy |
3,157
+169
| +6% | +$131K | 0.18% | 154 |
|
2023
Q4 | $1.74M | Sell |
2,988
-114
| -4% | -$66.5K | 0.13% | 188 |
|
2023
Q3 | $1.67M | Buy |
+3,102
| New | +$1.67M | 0.14% | 181 |
|
2023
Q2 | – | Sell |
-2,590
| Closed | -$890K | – | 428 |
|
2023
Q1 | $890K | Sell |
2,590
-39
| -1% | -$13.4K | 0.08% | 224 |
|
2022
Q4 | $961K | Sell |
2,629
-577
| -18% | -$211K | 0.1% | 216 |
|
2022
Q3 | $1.04M | Buy |
3,206
+707
| +28% | +$228K | 0.09% | 210 |
|
2022
Q2 | $810K | Buy |
2,499
+105
| +4% | +$34K | 0.09% | 227 |
|
2022
Q1 | $685K | Buy |
2,394
+2
| +0.1% | +$572 | 0.07% | 253 |
|
2021
Q4 | $660K | Buy |
2,392
+399
| +20% | +$110K | 0.06% | 254 |
|
2021
Q3 | $460K | Sell |
1,993
-2
| -0.1% | -$462 | 0.05% | 309 |
|
2021
Q2 | $458K | Sell |
1,995
-81
| -4% | -$18.6K | 0.05% | 307 |
|
2021
Q1 | $387K | Buy |
2,076
+718
| +53% | +$134K | 0.05% | 347 |
|
2020
Q4 | $229K | Buy |
+1,358
| New | +$229K | 0.03% | 409 |
|
2020
Q3 | – | Sell |
-1,317
| Closed | -$216K | – | 414 |
|
2020
Q2 | $216K | Sell |
1,317
-181
| -12% | -$29.7K | 0.04% | 363 |
|
2020
Q1 | $207K | Buy |
+1,498
| New | +$207K | 0.05% | 331 |
|